SMXT, ANVS and IFBD among pre-market losers

seekingalpha

2024-02-28

Losers: Oragenics (OGEN) -45% after pricing $2.1M stock offering.
Palatin Technologies (PTN) -37% announces results of PL9643 MELODY-1 pivotal phase 3 clinical trial in patients with dry eye disease.
Integral Ad Science Holding Corp (IAS) -26% after Q4 earnings release.
Novavax (NVAX) -19% reports fourth Quarter and full year 2023 financial results and operational highlights.
SolarMax Technology (SMXT) -18%.
3D Systems Corp. (DDD) -17% after Q4 earnings release.
Vertex Energy (VTNR) -17% reports Q4 results.
Lemonade (LMND) -16% after Q4 earnings release.
DoubleVerify Holdings (DV) -14%.
Sarcos Technology and Robotics Corporation (STRC) -14%.
Payoneer Global (PAYO) -13% after Q4 earnings release.
Annovis Bio (ANVS) -12%.
Amesite (AMST) -12%.
Bumble (BMBL) -12% after Q4 earnings release.
Recursion Pharmaceuticals (RXRX) -11% after Q4 earnings release.
Luminar Technologies (LAZR) -10% after Q4 earnings release.
Infobird Co Ltd (IFBD) -9%.
Cellectis (CLLS) -7%.
Virgin Galactic Holdings (SPCE) -7% after Q4 earnings release.
Bit Origin Ltd (BTOG) -7%.
Fusion Fuel Green Ltd (HTOO) -6%.
reAlpha Tech Corp. (AIRE) -5%.
Opko Health (OPK) -6% after Q4 earnings release.

More on pre-market losers & stocks.

Annovis: Potentially Encouraging Anecdotes, Weighing Phase 3 Parkinson's Prospects
Annovis And Alzheimer's Disease: The Best-Laid Plans
Stocks To Watch: Eyes On Chipmakers, Tesla, Netflix And BrightSpring IPO
Infobird to effect 1-for-8 reverse stock split to regain compliance with Nasdaq rules
Annovis falls 16% on Phase 3 data delay for Parkinson's drug

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2414432421"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2414432421\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2414432421?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-02-28 21:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2414432421","market":"fut","top_or_hot":-1,"title":"SMXT, ANVS and IFBD among pre-market losers","media":"seekingalpha","content":"<html><body><ul> <li> <b>Losers: </b>Oragenics (OGEN) <span>-45%</span> after pricing $2.1M stock offering.</li> <li>Palatin Technologies (PTN) <span>-37% </span>announces results of PL9643 MELODY-1 pivotal phase 3 clinical trial in patients with dry eye disease.</li> <li><a href=\"https://laohu8.com/S/IAS\">Integral Ad Science Holding</a> Corp (IAS) <span>-26%</span> after Q4 earnings release.</li> <li>Novavax (NVAX) <span>-19%</span><span> reports </span>fourth Quarter and full year 2023 financial results and operational highlights<span>.</span> </li> <li><a href=\"https://laohu8.com/S/SMXT\">SolarMax Technology</a> (SMXT) <span>-18%</span>.</li> <li>3D Systems Corp. (DDD) <span>-17%</span> after Q4 earnings release.</li> <li>Vertex Energy (VTNR) <span>-17%</span> reports Q4 results.</li> <li>Lemonade (LMND) <span>-16%</span> after Q4 earnings release.</li> <li>DoubleVerify Holdings (DV) <span>-14%</span>.</li> <li>Sarcos Technology and Robotics Corporation (STRC) <span>-14%</span>.</li> <li>Payoneer Global (PAYO) <span>-13%</span> after Q4 earnings release.</li> <li>Annovis Bio (ANVS) <span>-12%</span>.</li> <li>Amesite (AMST) <span>-12%</span>.</li> <li>Bumble (BMBL) <span>-12%</span> after Q4 earnings release.</li> <li>Recursion Pharmaceuticals (RXRX) <span>-11%</span> after Q4 earnings release.</li> <li>Luminar Technologies (LAZR) <span>-10%</span> after Q4 earnings release.</li> <li>Infobird Co Ltd (IFBD) <span>-9%</span>.</li> <li>Cellectis (CLLS) <span>-7%</span>.</li> <li>Virgin Galactic Holdings (SPCE) <span>-7%</span> after Q4 earnings release.</li> <li><a href=\"https://laohu8.com/S/BTOG\">Bit Origin</a> Ltd (BTOG) <span>-7%</span>.</li> <li>Fusion Fuel Green Ltd (HTOO) <span>-6%</span>.</li> <li><a href=\"https://laohu8.com/S/AIRE\">reAlpha Tech Corp.</a> (AIRE) <span>-5%</span>.</li> <li><a href=\"https://laohu8.com/S/OPK\">Opko Health</a> (OPK) <span>-6%</span> after Q4 earnings release.</li> </ul> <div> <h2>More on pre-market losers &amp; stocks.</h2> <ul> <li>Annovis: Potentially Encouraging Anecdotes, Weighing Phase 3 Parkinson's Prospects</li> <li>Annovis And Alzheimer's Disease: The Best-Laid Plans</li> <li>Stocks To Watch: Eyes On Chipmakers, Tesla, Netflix And BrightSpring IPO</li> <li>Infobird to effect 1-for-8 reverse stock split to regain compliance with Nasdaq rules</li> <li>Annovis falls 16% on Phase 3 data delay for Parkinson's drug</li> </ul> </div></body></html>","source":"seekingalpha_hot_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SMXT, ANVS and IFBD among pre-market losers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSMXT, ANVS and IFBD among pre-market losers\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">seekingalpha</strong><span class=\"h-time small\">2024-02-28 21:25</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><ul> <li> <b>Losers: </b>Oragenics (OGEN) <span>-45%</span> after pricing $2.1M stock offering.</li> <li>Palatin Technologies (PTN) <span>-37% </span>announces results of PL9643 MELODY-1 pivotal phase 3 clinical trial in patients with dry eye disease.</li> <li><a href=\"https://laohu8.com/S/IAS\">Integral Ad Science Holding</a> Corp (IAS) <span>-26%</span> after Q4 earnings release.</li> <li>Novavax (NVAX) <span>-19%</span><span> reports </span>fourth Quarter and full year 2023 financial results and operational highlights<span>.</span> </li> <li><a href=\"https://laohu8.com/S/SMXT\">SolarMax Technology</a> (SMXT) <span>-18%</span>.</li> <li>3D Systems Corp. (DDD) <span>-17%</span> after Q4 earnings release.</li> <li>Vertex Energy (VTNR) <span>-17%</span> reports Q4 results.</li> <li>Lemonade (LMND) <span>-16%</span> after Q4 earnings release.</li> <li>DoubleVerify Holdings (DV) <span>-14%</span>.</li> <li>Sarcos Technology and Robotics Corporation (STRC) <span>-14%</span>.</li> <li>Payoneer Global (PAYO) <span>-13%</span> after Q4 earnings release.</li> <li>Annovis Bio (ANVS) <span>-12%</span>.</li> <li>Amesite (AMST) <span>-12%</span>.</li> <li>Bumble (BMBL) <span>-12%</span> after Q4 earnings release.</li> <li>Recursion Pharmaceuticals (RXRX) <span>-11%</span> after Q4 earnings release.</li> <li>Luminar Technologies (LAZR) <span>-10%</span> after Q4 earnings release.</li> <li>Infobird Co Ltd (IFBD) <span>-9%</span>.</li> <li>Cellectis (CLLS) <span>-7%</span>.</li> <li>Virgin Galactic Holdings (SPCE) <span>-7%</span> after Q4 earnings release.</li> <li><a href=\"https://laohu8.com/S/BTOG\">Bit Origin</a> Ltd (BTOG) <span>-7%</span>.</li> <li>Fusion Fuel Green Ltd (HTOO) <span>-6%</span>.</li> <li><a href=\"https://laohu8.com/S/AIRE\">reAlpha Tech Corp.</a> (AIRE) <span>-5%</span>.</li> <li><a href=\"https://laohu8.com/S/OPK\">Opko Health</a> (OPK) <span>-6%</span> after Q4 earnings release.</li> </ul> <div> <h2>More on pre-market losers &amp; stocks.</h2> <ul> <li>Annovis: Potentially Encouraging Anecdotes, Weighing Phase 3 Parkinson's Prospects</li> <li>Annovis And Alzheimer's Disease: The Best-Laid Plans</li> <li>Stocks To Watch: Eyes On Chipmakers, Tesla, Netflix And BrightSpring IPO</li> <li>Infobird to effect 1-for-8 reverse stock split to regain compliance with Nasdaq rules</li> <li>Annovis falls 16% on Phase 3 data delay for Parkinson's drug</li> </ul> </div></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://seekingalpha.com/news/4072977-smxt-anvs-and-ifbd-among-pre-market-losers\">seekingalpha</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DV","symbol_name":"DoubleVerify Holdings, Inc.","start_time":0,"source_url":"https://seekingalpha.com/news/4072977-smxt-anvs-and-ifbd-among-pre-market-losers","article_id":"2414432421","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2414432421","pubTimestamp":1709126744,"columns":[],"sourceInfo":{"source_id":"seekingalpha_hot_news","name":"SeekingAlpha"},"weMediaInfo":null,"summary":"Losers: Oragenics (OGEN) -45% after pricing $2.1M stock offering. Palatin Technologies (PTN) -37% announces results of PL9643 MELODY-1 pivotal phase 3 clinical trial in patients with dry eye disease. ","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"DV":"DoubleVerify Holdings, Inc.","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","LU1548497426.USD":"安联环球人工智能AT Acc","BK4138":"石油与天然气的炼制和营销","ANVS":"Annovis Bio, Inc.","AIRE":"reAlpha Tech Corp.","IAS":"Integral Ad Science Holding","RXRX":"Recursion Pharmaceuticals, Inc.","BK4562":"SPAC上市公司","OPK":"Opko Health","IFBD":"讯鸟软件","HTOO":"Fusion Fuel Green PLC","BK4564":"太空概念","PAYO":"Payoneer Global Inc.","DDD":"3D系统","BK4204":"教育服务","AMST":"Amesite Inc.","LU1429558221.USD":"Natixis Loomis Sayles US Growth Equity RA USD","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","IE00B19Z9505.USD":"美盛-美国大盘成长股A Acc","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","LU1435385759.SGD":"Natixis Loomis Sayles US Growth Equity RA SGD-H","BK4139":"生物科技","PTN":"Palatin Technologies Inc","LMND":"Lemonade, Inc.","BTOG":"Bit Origin","BK4566":"资本集团","LU0082616367.USD":"摩根大通美国科技A（dist）","SPCE":"维珍银河","SMXT":"SolarMax Technology","BK4196":"保健护理服务","BK4587":"ChatGPT概念","VTNR":"顶点能源","BK4009":"广告","LU1823568750.SGD":"Fidelity Global Technology A-ACC SGD","BK4535":"淡马锡持仓","BK4077":"互动媒体与服务","BK4568":"美国抗疫概念","BK4537":"激光雷达概念","NFLX":"奈飞","LAZR":"Luminar Technologies, Inc.","BK4551":"寇图资本持仓","OGEN":"Oragenics Inc.","BMBL":"Bumble Inc.","NVAX":"诺瓦瓦克斯医药","BK4096":"电气部件与设备","CLLS":"Cellectis S.A."},"translate_title":"SMXT、ANVS和IFBD是盘前输家","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AIRE":1,"AMST":1,"ANVS":1,"BMBL":1,"BTOG":1,"CLLS":1,"DDD":1,"DV":1,"HTOO":1,"IAS":1,"IFBD":1,"LAZR":1,"LMND":1,"NFLX":0.61,"NVAX":1,"OGEN":1,"OPK":1,"PAYO":1,"PTN":1,"RXRX":1,"SMXT":1,"SPCE":1,"STRC":1,"VTNR":1},"content_text":"Losers: Oragenics (OGEN) -45% after pricing $2.1M stock offering. Palatin Technologies (PTN) -37% announces results of PL9643 MELODY-1 pivotal phase 3 clinical trial in patients with dry eye disease. Integral Ad Science Holding Corp (IAS) -26% after Q4 earnings release. Novavax (NVAX) -19% reports fourth Quarter and full year 2023 financial results and operational highlights.  SolarMax Technology (SMXT) -18%. 3D Systems Corp. (DDD) -17% after Q4 earnings release. Vertex Energy (VTNR) -17% reports Q4 results. Lemonade (LMND) -16% after Q4 earnings release. DoubleVerify Holdings (DV) -14%. Sarcos Technology and Robotics Corporation (STRC) -14%. Payoneer Global (PAYO) -13% after Q4 earnings release. Annovis Bio (ANVS) -12%. Amesite (AMST) -12%. Bumble (BMBL) -12% after Q4 earnings release. Recursion Pharmaceuticals (RXRX) -11% after Q4 earnings release. Luminar Technologies (LAZR) -10% after Q4 earnings release. Infobird Co Ltd (IFBD) -9%. Cellectis (CLLS) -7%. Virgin Galactic Holdings (SPCE) -7% after Q4 earnings release. Bit Origin Ltd (BTOG) -7%. Fusion Fuel Green Ltd (HTOO) -6%. reAlpha Tech Corp. (AIRE) -5%. Opko Health (OPK) -6% after Q4 earnings release.   More on pre-market losers & stocks.  Annovis: Potentially Encouraging Anecdotes, Weighing Phase 3 Parkinson's Prospects Annovis And Alzheimer's Disease: The Best-Laid Plans Stocks To Watch: Eyes On Chipmakers, Tesla, Netflix And BrightSpring IPO Infobird to effect 1-for-8 reverse stock split to regain compliance with Nasdaq rules Annovis falls 16% on Phase 3 data delay for Parkinson's drug","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}